X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2024-09-05 | ACLX | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale+OE | $70.02 | -3,421 | 9,278 | -27% | -$239,526 | |||||
D | 2024-09-03 | ACLX | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale+OE | $67.03 | -27,451 | 9,278 | -75% | -$1,840,053 | |||||
D | 2024-08-26 | ACLX | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale+OE | $71.13 | -21,684 | 9,278 | -70% | -$1,542,274 | |||||
D | 2024-08-16 | ACLX | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale+OE | $65.05 | -5,450 | 9,278 | -37% | -$354,526 | |||||
D | 2024-08-01 | ACLX | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale+OE | $60.42 | -20,000 | 9,278 | -68% | -$1,208,435 | |||||
D | 2024-07-16 | ACLX | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale+OE | $65.30 | -10,901 | 9,278 | -54% | -$711,854 | |||||
DM | 2024-07-11 | ACLX | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale+OE | $60.08 | -5,451 | 9,278 | -37% | -$327,477 | |||||
D | 2024-07-01 | ACLX | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale+OE | $55.39 | -20,000 | 9,278 | -68% | -$1,107,763 | |||||
D | 2024-06-12 | ACLX | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale+OE | $55.13 | -20,000 | 9,278 | -68% | -$1,102,668 | |||||
D | 2024-05-01 | ACLX | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale+OE | $51.33 | -18,168 | 8,938 | -67% | -$932,557 | |||||
DM | 2024-03-22 | ACLX | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale+OE | $70.06 | -46,815 | 8,938 | -84% | -$3,279,714 | |||||
M | 2024-02-08 | ACLX | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale | $63.33 | -10,111 | 30,303 | -25% | -$640,352 | |||||
2024-01-04 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale | $55.27 | -7,598 | 17,859 | -30% | -$419,926 | ||||||
D | 2023-12-18 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $50.17 | -120,000 | 7,795 | -94% | -$6,020,281 | |||||
D | 2023-08-04 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $35.38 | -3,000 | 7,795 | -28% | -$106,133 | |||||
D | 2023-07-03 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $31.75 | -3,000 | 7,795 | -28% | -$95,246 | |||||
M | 2023-05-09 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale | $45.15 | -2,697 | 7,795 | -26% | -$121,766 | |||||
2023-05-05 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale | $45.00 | -1,200 | 10,492 | -10% | -$54,002 | ||||||
D | 2023-05-03 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $43.44 | -3,000 | 11,692 | -20% | -$130,329 | |||||
D | 2023-04-24 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $40.00 | -20,000 | 11,692 | -63% | -$800,068 | |||||
DM | 2023-04-18 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $35.01 | -21,642 | 11,692 | -65% | -$757,661 | |||||
D | 2023-04-03 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $30.71 | -3,000 | 15,589 | -16% | -$92,121 | |||||
D | 2023-02-09 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $30.77 | -6,966 | 15,589 | -31% | -$214,333 | |||||
D | 2023-02-03 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $35.11 | -1,255 | 0 | -100% | -$44,068 | |||||
D | 2023-01-03 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $31.11 | -2,500 | 0 | -100% | -$77,775 | |||||
D | 2022-12-13 | ACLX | Heery Christopher | Chief Medical Officer | S - Sale+OE | $30.03 | -12,500 | 0 | -100% | -$375,320 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |